Endobronchial ultrasound: a guide to mediastinal disorders
Journal Title: Current Thoracic Surgery - Year 2016, Vol 1, Issue 1
Abstract
In the last decade endobronchial ultrasound with real-time guided needle aspiration (EBUS-NA) has been recognized worldwide as a tool with remarkable impact on routine clinical practice. In the present review article, we focus on specific disease-related features of EBUS-NA, including diagnosis and staging of thoracic malignancies, sarcoidosis, tuberculosis and its role in the evaluation of isolated enlarged mediastinal lymph nodes. We also address some less common conditions and discuss emerging and future developments in EBUS technique
Authors and Affiliations
António Bugalho
Keywords
Related Articles
- EP ID EP288941
- DOI 10.26663/cts.2016.0010
- Views 100
- Downloads 0
Axillary thoracotomy and VATS for the treatment of primary spontaneous pneumothorax
Background: The aim of this study is to examine the recurrence rates and their causes after axillary thoracotomy and VATS for the treatment of primary spontaneous pneumothorax (PSP). Materials and Methods: Patients who...
Primary malignant mediastinal germ cell tumor in childhood
Primary malignant mediastinal germ cell tumors are rare in childhood. Despite the metastasis to lung, liver, brain and bone is possible but sternal metastasis is unusual. Both tumor and its metastases treated with surgic...
Current surgical management of extrapulmonary oligometastatic non-small cell lung carcinoma
Lung cancer is one of the leading cause of mortality around the world, and it is widely known that survival is limited in metastatic lung carcinoma cases. However, in oligometastatic, non-small cell lung carcinoma cases,...
Current treatment options for post-thoracotomy pain syndrome: a review
Thoracotomy is one of the most painful surgical procedures known. Chronic pain in the postoperative period after thoracotomy is a common complication. Post-thoracotomy pain syndrome (PTPS) is a chronic pain with neuropat...
Upregulated mRNA expression of mTOR in surgically resected early stage non-small cell lung carcinoma: a potential molecular targeted therapy
Background: Non-small cell lung cancer (NSCLC) comprises about 85% of all lung cancers. Although many attempts for early detection and treatment, prognosis of NSCLC is still poor. In recent years the pathways and the ge...